Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Mei Yang, Ting Yang, Xiaoou Li, Diandian Li, Zenglin Liao, Yongchun Shen, Dan Xu, Lei Chen & Fuqiang Wen. (2021) Clinical Predictors of High Blood Eosinophils in Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2467-2474.
Read now
Read now
Peter J. Barnes. (2021) Endo-phenotyping of COPD patients. Expert Review of Respiratory Medicine 15:1, pages 27-37.
Read now
Read now
Sandra Martínez-Gestoso, María-Teresa García-Sanz, Uxío Calvo-Álvarez, Liliana Doval-Oubiña, Sandra Camba-Matos, Francisco-Javier Salgado, Xavier Muñoz, Purificación Perez-Lopez-Corona & Francisco-Javier González-Barcala. (2021) Variability of blood eosinophil count and prognosis of COPD exacerbations. Annals of Medicine 53:1, pages 1153-1159.
Read now
Read now
Ming Chiu Chan, Yiu Cheong Yeung, Ellen Lok Man Yu & Wai Cho Yu. (2020) Blood Eosinophil and Risk of Exacerbation in Chronic Obstructive Pulmonary Disease Patients: A Retrospective Cohort Analysis. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2869-2877.
Read now
Read now
Victoria S Benson, Katie C Pascoe, James Siddall, Mark Small & Hana Müllerová. (2019) Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2711-2723.
Read now
Read now
Hana Müllerová, Wilhelmine H Meeraus, Dmitry V Galkin, Frank C Albers & Sarah H Landis. (2019) Clinical burden of illness among patients with severe eosinophilic COPD. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 741-755.
Read now
Read now
Hana Müllerová, Beth Hahn, Edgar P Simard, George Mu & Umur Hatipoğlu. (2019) Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 683-692.
Read now
Read now
Articles from other publishers (26)
N. V. Trushenko, B. B. Lavginova, G. S. Nuralieva & S. N. Avdeev. (2023) Clinical efficacy of a triple combination of budesonide/ glycopyrronium bromide/formoterol in the treatment of chronic obstructive pulmonary disease. Meditsinskiy sovet = Medical Council:20, pages 10-17.
Crossref
Crossref
W. Blake LeMaster, P. Miguel Quibrera, David Couper, Donald P. Tashkin, Eugene R. Bleecker, Claire M. Doerschuk, Victor E. Ortega, Christopher Cooper, MeiLan K. Han, Prescott G. Woodruff, Wanda K. O’Neal, Wayne H. Anderson, Neil E. Alexis, Russell P. Bowler, R. Graham Barr, Robert J. Kaner, Mark T. Dransfield, Robert PaineIIIIII, Victor Kim, Jeffrey L. Curtis, Fernando J. Martinez, Annette T. Hastie & Igor Barjaktarevic. (2023) Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD Cohort. Chest 163:3, pages 515-528.
Crossref
Crossref
Marc Miravitlles, Juan José Soler-Cataluña, Joan B. Soriano, Francisco García-Río, Pilar de Lucas, Inmaculada Alfageme, Ciro Casanova, José Miguel Rodríguez González-Moro, M. Guadalupe Sánchez-Herrero, Julio Ancochea & Borja G. Cosío. (2022) Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study. Respiratory Research 23:1.
Crossref
Crossref
Nora Drick, Jan Fuge, Benjamin Seeliger, Milan Speth, Jens Vogel-Claussen, Tobias Welte & Hendrik Suhling. (2022) Treatment with interleukin (IL)-5/IL-5 receptor antibodies in patients with severe eosinophilic asthma and COPD. ERJ Open Research 8:4, pages 00207-2022.
Crossref
Crossref
Alexandrosz Czira, Victoria Banks, Gema Requena, Robert Wood, Theo Tritton, Rosie Wild, Chris Compton, Maria Duarte & Afisi S Ismaila. (2022)
Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β
2
-agonist dual therapy in a primary care setting in England
. BMJ Open Respiratory Research 9:1, pages e001243.
Crossref
Crossref
I. Yu. Vizel, I. N. Salakhova, A. A. Vizel, G. R. Shakirova, E. Z. Kudryavtseva & A. R. Vafina. (2022) Peripheral blood eosinophil count in COPD: literature data and new findings. PULMONOLOGIYA 32:1, pages 68-76.
Crossref
Crossref
Victoria S. Benson, Sylvia Hartl, Neil Barnes, Nicholas Galwey, Melissa K. Van Dyke & Namhee Kwon. (2022) Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis. European Respiratory Journal 59:1, pages 2004590.
Crossref
Crossref
Jens Ellingsen, Christer Janson, Kristina Bröms, Karin Lisspers, Björn Ställberg, Marieann Högman & Andrei Malinovschi. (2021) Neutrophil-to-lymphocyte ratio, blood eosinophils and COPD exacerbations: a cohort study. ERJ Open Research 7:4, pages 00471-2021.
Crossref
Crossref
Hye Yun Park, Yoosoo Chang, Danbee Kang, Yun Soo Hong, Di Zhao, Jiin Ahn, Sun Hye Shin, Dave Singh, Eliseo Guallar, Juhee Cho & Seungho Ryu. (2021) Blood eosinophil counts and the development of obstructive lung disease: the Kangbuk Samsung Health Study. European Respiratory Journal 58:4, pages 2003823.
Crossref
Crossref
Shanya Sivakumaran, Mohammad A. Alsallakh, Ronan A. Lyons, Jennifer K. Quint & Gwyneth A. Davies. (2021) Identifying COPD in routinely collected electronic health records: a systematic scoping review. ERJ Open Research 7:3, pages 00167-2021.
Crossref
Crossref
Sumitra Shantakumar, Yu-Fan Ho, Janine Beale & Barry Gribben. (2021) Burden of illness in blood eosinophilic phenotype COPD patients in New Zealand. Respiratory Investigation 59:4, pages 487-497.
Crossref
Crossref
Yasemin Kandemir, Nurettin Özgür Doğan, Elif Yaka, Murat Pekdemir & Serkan Yılmaz. (2021) Clinical characteristics of neutrophilic, eosinophilic and mixed-type exacerbation phenotypes of COPD. The American Journal of Emergency Medicine 45, pages 237-241.
Crossref
Crossref
Peter M. A. Calverley & Paul Phillip Walker. (2021) ACO (Asthma–COPD Overlap) Is Independent from COPD: The Case Against. Diagnostics 11:7, pages 1189.
Crossref
Crossref
Rita Amaral, Tiago Jacinto, Andrei Malinovschi, Christer Janson, David Price, João A. Fonseca & Kjell Alving. (2021) The influence of individual characteristics and non‐respiratory diseases on blood eosinophil count. Clinical and Translational Allergy 11:4.
Crossref
Crossref
Hong-Xiang Liu, Na Cui & Yi-Fan Li. (2021) Review on the correlation between chronic obstructive pulmonary disease and eosinophil in peripheral blood. European Journal of Inflammation 19, pages 205873922199818.
Crossref
Crossref
Tao Liu, Zi-Jian Xiang, Xiao-Meng Hou, Jing-Jing Chai, Yan-Li Yang & Xiao-Tong Zhang. (2021) Blood eosinophil count-guided corticosteroid therapy and as a prognostic biomarker of exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Therapeutic Advances in Chronic Disease 12, pages 204062232110287.
Crossref
Crossref
Marc Miravitlles, Mònica Monteagudo, Iryna Solntseva & Bernardino Alcázar. (2021) Blood Eosinophil Counts and Their Variability and Risk of Exacerbations in COPD: A Population-Based Study. Archivos de Bronconeumología 57:1, pages 13-20.
Crossref
Crossref
Marc Miravitlles, Mònica Monteagudo, Iryna Solntseva & Bernardino Alcázar. (2021) Blood Eosinophil Counts and Their Variability and Risk of Exacerbations in COPD: A Population-Based Study. Archivos de Bronconeumología (English Edition) 57:1, pages 13-20.
Crossref
Crossref
Sylvia Hartl, Marie-Kathrin Breyer, Otto C. Burghuber, Alina Ofenheimer, Andrea Schrott, Matthias H. Urban, Alvar Agusti, Michael Studnicka, Emiel F.M. Wouters & Robab Breyer-Kohansal. (2020) Blood eosinophil count in the general population: typical values and potential confounders. European Respiratory Journal 55:5, pages 1901874.
Crossref
Crossref
Signe Vedel-Krogh. (2020) The search for the “healthy” blood eosinophil count. European Respiratory Journal 55:5, pages 2000473.
Crossref
Crossref
Ahmed Ben Saad, Rim Khemakhem, Saousen Cheikh Mhamed, Nesrine Fahem, Asma Migaou, Samah Joobeur & Naceur Rouatbi. (2019) Etude de l’intérêt de l’éosinophilie sanguine au cours des exacerbations aiguës sévères de bronchopneumopathie chronique obstructive (BPCO) dans un centre tunisien. Pan African Medical Journal 34.
Crossref
Crossref
S N Avdeev, N V Trushenko, Z M Merzhoeva, M S Ivanova & E V Kusraeva. (2019) Eosinophilic inflammation in chronic obstructive pulmonary disease. Terapevticheskii arkhiv 91:10, pages 144-152.
Crossref
Crossref
Salvatore Fuschillo, Antonio Molino, Cristiana Stellato, Andrea Motta & Mauro Maniscalco. (2019) Blood eosinophils as biomarkers of therapeutic response to chronic obstructive pulmonary disease: Still work in progress. European Journal of Internal Medicine 68, pages 1-5.
Crossref
Crossref
Dave Singh, Alvar Agusti, Antonio Anzueto, Peter J. Barnes, Jean Bourbeau, Bartolome R. Celli, Gerard J. Criner, Peter Frith, David M.G. Halpin, Meilan Han, M. Victorina López Varela, Fernando Martinez, Maria Montes de Oca, Alberto Papi, Ian D. Pavord, Nicolas Roche, Donald D. Sin, Robert Stockley, Jørgen Vestbo, Jadwiga A. Wedzicha & Claus Vogelmeier. (2019) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. European Respiratory Journal 53:5, pages 1900164.
Crossref
Crossref
Peter J. Barnes. (2019) Inflammatory endotypes in COPD. Allergy.
Crossref
Crossref
Sarah H. Landis, Jeanne M. Pimenta, Shibing Yang, Chris Compton, Neil Barnes & Guy Brusselle. (2019) Association between blood eosinophils and acute exacerbation of COPD risk in patients with COPD in primary care. Respiratory Medicine: X 1, pages 100011.
Crossref
Crossref